IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Yu Fan

Q4 2020 Holdings

Filed 2021-02-16 | 1 holdings | $20.9K | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2021-05-17) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Atea Pharmaceuticals Inc(AVIR)COM04683R106$12.5M300,000100.0%
Pulmonx Corp(LUNG)ACOM745848101$20.9K303,030100.0%
Aeglea Biotherapeutics Inc(AGLEUSD)COM00773J103$882112,0440.0%
Diffusion Pharmaceuticals inCOM PAR253748305$7189,8480.0%